DRUG MONITORING OF MYCOPHENOLIC ACID (MPA) IN A RENAL TRANSPLANT POPULATION: DISTRIBUTION OF ESTIMATED AREA UNDER THE CURVE (AUC), IN DIFFERENT POST-TRANSPLANT PERIODS

被引：0

作者：

Amy, Crosthwaite ^{[1
]}

Andrew, Ellis ^{[1
]}

Albert, Frauman ^{[1
]}

Francesco, Ierino ^{[1
]}

机构：

[1] Austin Hlth, Melbourne, Vic, Australia

来源：

IMMUNOLOGY AND CELL BIOLOGY | 2009年 / 87卷 / 06期

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：A11 / A11

页数：1

共 50 条

[1] The Importance of Monitoring Mycophenolic Acid Area-under-Curve (MPA AUC) Levels To Prevent the Development of HLA Antibodies in Renal Transplant Patients
Krecko, K. R.
Yang, H. C.
Waybill, M. M.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 418 - 418
[2] Limited sampling strategy for estimation of mycophenolic acid (MPA) area under the curve (AUC) in hematopoietic cell transplant (HCT) patients.
Ng, JW
Rogosheske, J
Jacobson, P
[J]. PHARMACOTHERAPY, 2004, 24 (10): : 1466 - 1466
[3] Mycophenolic acid therapeutic drug monitoring using area under the curve in pediatric heart transplant recipients
Newland, David M.
Pak, Jennifer L.
Ali, Reda
Herzog, Thiebaut
Nemeth, Thomas L.
Tressel, William
Kronmal, Richard A.
Knorr, Lisa R.
Albers, Erin L.
Friedland-Little, Joshua M.
Ahmed, Humera
Kemna, Mariska S.
Hong, Borah J.
Spencer, Kathryn
Law, Yuk M.
[J]. CLINICAL TRANSPLANTATION, 2023, 37 (11)
[4] Mycophenolic Acid Therapeutic Drug Monitoring Using Area Under the Curve in Pediatric Heart Transplant Recipients
Newland, D. M.
Pak, J. L.
Ali, R.
Nemeth, T. L.
Tressel, W.
Kronmal, R.
Albers, E. L.
Friedland-Little, J. M.
Ahmed, H.
Kemna, M. S.
Hong, B. J.
Spencer, K. L.
Law, Y. M.
[J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S156 - S156
[5] Steroid therapy is associated with smaller mycophenolic acid (MPA) area under curve (AUC)
Fickl, R
Mazouz, H
Westeel, PF
Harbouche, L
Monge, M
Harry, L
Hurtel, AS
Choukroun, G
Fournier, A
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V167 - V167
[6] Therapeutic drug monitoring of mycophenolic acid in paediatric kidney transplant recipients at least three months post-transplant
Kang, Han Byul
Chung, Erin
Nalli, Nadya
Manchharam, Dipti
Seto, Winnie
Lau, Janice
Teoh, Chia Wei
Williams, Angela
Woo, Renee
[J]. PEDIATRIC TRANSPLANTATION, 2022, 26
[7] Population pharmacokinetics of mycophenolic acid in lung transplant adults in the early post-transplant period
Kauv, J.
Feuillet, S.
Barrail-Tran, A.
Verstuyft, C.
Delemos, A.
Comets, E.
Furlan, V.
[J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 103 - 104
[8] Therapeutic drug monitoring of mycophenolic acid in renal transplant recipients
Okamoto, M
Wakabayashi, Y
Higuchi, A
Kadotani, Y
Ogino, S
Ushigome, H
Akioka, K
Kaihara, S
Yoshimura, N
[J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 859 - 860
[9] Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period
Dong, Min
Fukuda, Tsuyoshi
Cox, Shareen
de Vries, Marij T.
Hooper, David K.
Goebel, Jens
Vinks, Alexander A.
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (05) : 1102 - 1112
[10] Therapeutic Mycophenolic Acid Area-Under-Curve (MPA AUC) Levels Abolish Donor-Specific Antibody Formation in Established and De Novo Renal Transplant Patients.
Waybill, M.
Narins, S.
Scott, R.
Yang, H.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 329 - 329

← 1 2 3 4 5 →